TY - JOUR AU - Galon, J. AU - Costes, A. AU - Sanchez-Cabo, F. AU - Kirilovsky, A. AU - Mlecnik, B. AU - Lagorce-Pages, C. PY - 2006 DA - 2006// TI - Type, density, and location of immune cells within human colorectal tumors predict clinical outcome JO - Science VL - 313 UR - https://doi.org/10.1126/science.1129139 DO - 10.1126/science.1129139 ID - Galon2006 ER - TY - JOUR AU - Galon, J. AU - Pages, F. AU - Marincola, F. M. AU - Thurin, M. AU - Trinchieri, G. AU - Fox, B. A. PY - 2012 DA - 2012// TI - The immune score as a new possible approach for the classification of cancer JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-1 DO - 10.1186/1479-5876-10-1 ID - Galon2012 ER - TY - JOUR AU - Chen, D. S. AU - Irving, B. A. AU - Hodi, F. S. PY - 2012 DA - 2012// TI - Molecular pathways: next-generation immunotherapy-inhibiting programmed death-ligand 1 and programmed death-1 JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1362 DO - 10.1158/1078-0432.CCR-12-1362 ID - Chen2012 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Hodi, F. S. AU - O’Day, S. J. AU - McDermott, D. F. AU - Weber, R. W. AU - Sosman, J. A. AU - Haanen, J. B. PY - 2010 DA - 2010// TI - Improved survival with ipilimumab in patients with metastatic melanoma JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1003466 DO - 10.1056/NEJMoa1003466 ID - Hodi2010 ER - TY - JOUR AU - Gajewski, T. F. PY - 2015 DA - 2015// TI - The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment JO - Semin Oncol VL - 42 UR - https://doi.org/10.1053/j.seminoncol.2015.05.011 DO - 10.1053/j.seminoncol.2015.05.011 ID - Gajewski2015 ER - TY - JOUR AU - Sharma, P. AU - Allison, J. P. PY - 2015 DA - 2015// TI - The future of immune checkpoint therapy JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa8172 DO - 10.1126/science.aaa8172 ID - Sharma2015 ER - TY - JOUR AU - Zhang, L. AU - Conejo-Garcia, J. R. AU - Katsaros, D. AU - Gimotty, P. A. AU - Massobrio, M. AU - Regnani, G. PY - 2003 DA - 2003// TI - Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa020177 DO - 10.1056/NEJMoa020177 ID - Zhang2003 ER - TY - JOUR AU - Fridman, W. H. AU - Pages, F. AU - Sautes-Fridman, C. AU - Galon, J. PY - 2012 DA - 2012// TI - The immune contexture in human tumours: impact on clinical outcome JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3245 DO - 10.1038/nrc3245 ID - Fridman2012 ER - TY - JOUR AU - Schmidt, M. AU - Hellwig, B. AU - Hammad, S. AU - Othman, A. AU - Lohr, M. AU - Chen, Z. PY - 2012 DA - 2012// TI - A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin kappa C as a compatible prognostic marker in human solid tumors JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2210 DO - 10.1158/1078-0432.CCR-11-2210 ID - Schmidt2012 ER - TY - JOUR AU - Nielsen, J. S. AU - Sahota, R. A. AU - Milne, K. AU - Kost, S. E. AU - Nesslinger, N. J. AU - Watson, P. H. PY - 2012 DA - 2012// TI - CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0234 DO - 10.1158/1078-0432.CCR-12-0234 ID - Nielsen2012 ER - TY - JOUR AU - Galon, J. AU - Fridman, W. H. AU - Pages, F. PY - 2007 DA - 2007// TI - The adaptive immunologic microenvironment in colorectal cancer: a novel perspective JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-4806 DO - 10.1158/0008-5472.CAN-06-4806 ID - Galon2007 ER - TY - JOUR AU - Mlecnik, B. AU - Bindea, G. AU - Pages, F. AU - Galon, J. PY - 2011 DA - 2011// TI - Tumor immunosurveillance in human cancers JO - Cancer Metastasis Rev VL - 30 UR - https://doi.org/10.1007/s10555-011-9270-7 DO - 10.1007/s10555-011-9270-7 ID - Mlecnik2011 ER - TY - JOUR AU - Mihm, M. C. AU - Clemente, C. G. AU - Cascinelli, N. PY - 1996 DA - 1996// TI - Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response JO - Lab Invest VL - 74 ID - Mihm1996 ER - TY - STD TI - Genomic Classification of Cutaneous Melanoma. Cell 2015, 161(7):1681–96. ID - ref15 ER - TY - JOUR AU - Visser, K. E. AU - Eichten, A. AU - Coussens, L. M. PY - 2006 DA - 2006// TI - Paradoxical roles of the immune system during cancer development JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1782 DO - 10.1038/nrc1782 ID - Visser2006 ER - TY - JOUR AU - Galon, J. AU - Angell, H. K. AU - Bedognetti, D. AU - Marincola, F. M. PY - 2013 DA - 2013// TI - The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures JO - Immunity VL - 39 UR - https://doi.org/10.1016/j.immuni.2013.07.008 DO - 10.1016/j.immuni.2013.07.008 ID - Galon2013 ER - TY - JOUR AU - Brahmer, J. R. AU - Tykodi, S. S. AU - Chow, L. Q. AU - Hwu, W. J. AU - Topalian, S. L. AU - Hwu, P. PY - 2012 DA - 2012// TI - Safety and activity of anti-PD-L1 antibody in patients with advanced cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200694 DO - 10.1056/NEJMoa1200694 ID - Brahmer2012 ER - TY - JOUR AU - Robert, C. AU - Thomas, L. AU - Bondarenko, I. AU - O’Day, S. AU - DJ, M. AU - Garbe, C. PY - 2011 DA - 2011// TI - Ipilimumab plus dacarbazine for previously untreated metastatic melanoma JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1104621 DO - 10.1056/NEJMoa1104621 ID - Robert2011 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. AU - Shintaku, I. P. AU - Taylor, E. J. AU - Robert, L. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - JOUR AU - Patel, S. P. AU - Kurzrock, R. PY - 2015 DA - 2015// TI - PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0983 DO - 10.1158/1535-7163.MCT-14-0983 ID - Patel2015 ER - TY - JOUR AU - Spranger, S. AU - Spaapen, R. M. AU - Zha, Y. AU - Williams, J. AU - Meng, Y. AU - Ha, T. T. PY - 2013 DA - 2013// TI - Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006504 DO - 10.1126/scitranslmed.3006504 ID - Spranger2013 ER - TY - JOUR AU - Herbst, R. S. AU - Soria, J. C. AU - Kowanetz, M. AU - Fine, G. D. AU - Hamid, O. AU - Gordon, M. S. PY - 2014 DA - 2014// TI - Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients JO - Nature VL - 515 UR - https://doi.org/10.1038/nature14011 DO - 10.1038/nature14011 ID - Herbst2014 ER - TY - JOUR AU - Inozume, T. AU - Hanada, K. AU - Wang, Q. J. AU - Ahmadzadeh, M. AU - Wunderlich, J. R. AU - Rosenberg, S. A. PY - 2010 DA - 2010// TI - Selection of CD8 + PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells JO - J Immunother VL - 33 UR - https://doi.org/10.1097/CJI.0b013e3181fad2b0 DO - 10.1097/CJI.0b013e3181fad2b0 ID - Inozume2010 ER - TY - JOUR AU - Gros, A. AU - Robbins, P. F. AU - Yao, X. AU - Li, Y. F. AU - Turcotte, S. AU - Tran, E. PY - 2014 DA - 2014// TI - PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI73639 DO - 10.1172/JCI73639 ID - Gros2014 ER - TY - JOUR AU - Ahmadzadeh, M. AU - Johnson, L. A. AU - Heemskerk, B. AU - Wunderlich, J. R. AU - Dudley, M. E. AU - White, D. E. PY - 2009 DA - 2009// TI - Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2008-12-195792 DO - 10.1182/blood-2008-12-195792 ID - Ahmadzadeh2009 ER - TY - JOUR AU - Baitsch, L. AU - Baumgaertner, P. AU - Devevre, E. AU - Raghav, S. K. AU - Legat, A. AU - Barba, L. PY - 2011 DA - 2011// TI - Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI46102 DO - 10.1172/JCI46102 ID - Baitsch2011 ER - TY - JOUR AU - Topalian, S. L. AU - Sznol, M. AU - McDermott, D. F. AU - Kluger, H. M. AU - Carvajal, R. D. AU - Sharfman, W. H. PY - 2014 DA - 2014// TI - Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.53.0105 DO - 10.1200/JCO.2013.53.0105 ID - Topalian2014 ER - TY - JOUR AU - Rizvi, N. A. AU - Mazieres, J. AU - Planchard, D. AU - Stinchcombe, T. E. AU - Dy, G. K. AU - Antonia, S. J. PY - 2015 DA - 2015// TI - Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70054-9 DO - 10.1016/S1470-2045(15)70054-9 ID - Rizvi2015 ER - TY - JOUR AU - Thompson, R. H. AU - Dong, H. AU - Lohse, C. M. AU - Leibovich, B. C. AU - Blute, M. L. AU - Cheville, J. C. PY - 2007 DA - 2007// TI - PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2599 DO - 10.1158/1078-0432.CCR-06-2599 ID - Thompson2007 ER - TY - JOUR AU - Pfreundschuh, M. AU - Shiku, H. AU - Takahashi, T. AU - Ueda, R. AU - Ransohoff, J. AU - Oettgen, H. F. PY - 1980 DA - 1980// TI - Tumor-specific antigens JO - Recent Results Cancer Res VL - 75 UR - https://doi.org/10.1007/978-3-642-81491-4_1 DO - 10.1007/978-3-642-81491-4_1 ID - Pfreundschuh1980 ER - TY - JOUR AU - Gnjatic, S. AU - Ritter, E. AU - Buchler, M. W. AU - Giese, N. A. AU - Brors, B. AU - Frei, C. PY - 2010 DA - 2010// TI - Seromic profiling of ovarian and pancreatic cancer JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.0914213107 DO - 10.1073/pnas.0914213107 ID - Gnjatic2010 ER - TY - JOUR AU - Lu, H. AU - Goodell, V. AU - Disis, M. L. PY - 2008 DA - 2008// TI - Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer JO - J Proteome Res VL - 7 UR - https://doi.org/10.1021/pr700818f DO - 10.1021/pr700818f ID - Lu2008 ER - TY - JOUR AU - Ohue, Y. AU - Wada, H. AU - Oka, M. AU - Nakayama, E. PY - 2014 DA - 2014// TI - Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients JO - Oncoimmunology VL - 3 UR - https://doi.org/10.4161/21624011.2014.970032 DO - 10.4161/21624011.2014.970032 ID - Ohue2014 ER - TY - STD TI - Ugel S, De Sanctis F, Mandruzzato S, Bronte V. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J Clin Invest. 2015;125(9):3356–64. ID - ref35 ER - TY - JOUR AU - Marvel, D. AU - Gabrilovich, D. I. PY - 2015 DA - 2015// TI - Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected JO - J Clin Invest VL - 2015 ID - Marvel2015 ER - TY - JOUR AU - Montero, A. J. AU - Diaz-Montero, C. M. AU - Kyriakopoulos, C. E. AU - Bronte, V. AU - Mandruzzato, S. PY - 2012 DA - 2012// TI - Myeloid-derived suppressor cells in cancer patients: a clinical perspective JO - J Immunother VL - 35 UR - https://doi.org/10.1097/CJI.0b013e318242169f DO - 10.1097/CJI.0b013e318242169f ID - Montero2012 ER - TY - JOUR AU - Bindea, G. AU - Mlecnik, B. AU - Fridman, W. H. AU - Pages, F. AU - Galon, J. PY - 2010 DA - 2010// TI - Natural immunity to cancer in humans JO - Curr Opin Immunol VL - 22 UR - https://doi.org/10.1016/j.coi.2010.02.006 DO - 10.1016/j.coi.2010.02.006 ID - Bindea2010 ER - TY - JOUR AU - Jochems, C. AU - Schlom, J. PY - 2011 DA - 2011// TI - Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity JO - Exp Biol Med (Maywood) VL - 236 UR - https://doi.org/10.1258/ebm.2011.011007 DO - 10.1258/ebm.2011.011007 ID - Jochems2011 ER - TY - JOUR AU - Berghoff, A. AU - Fuchs, E. AU - Ricken, G. AU - Mlecnik, B. AU - Bindea, G. AU - Spanberger, T. PY - 2016 DA - 2016// TI - Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2015.1057388 DO - 10.1080/2162402X.2015.1057388 ID - Berghoff2016 ER - TY - JOUR AU - Mlecnik, B. AU - Tosolini, M. AU - Charoentong, P. AU - Kirilovsky, A. AU - Bindea, G. AU - Berger, A. PY - 2010 DA - 2010// TI - Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer JO - Gastroenterology VL - 138 UR - https://doi.org/10.1053/j.gastro.2009.10.057 DO - 10.1053/j.gastro.2009.10.057 ID - Mlecnik2010 ER - TY - JOUR AU - Mlecnik, B. AU - Bindea, G. AU - Angell, H. K. AU - Sasso, M. S. AU - Obenauf, A. C. AU - Fredriksen, T. PY - 2014 DA - 2014// TI - Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3007240 DO - 10.1126/scitranslmed.3007240 ID - Mlecnik2014 ER - TY - JOUR AU - Jiang, Z. AU - Xu, Y. AU - Cai, S. PY - 2010 DA - 2010// TI - CXCL10 expression and prognostic significance in stage II and III colorectal cancer JO - Mol Biol Rep VL - 37 UR - https://doi.org/10.1007/s11033-009-9873-z DO - 10.1007/s11033-009-9873-z ID - Jiang2010 ER - TY - JOUR AU - Chen, L. J. AU - Zheng, X. AU - Shen, Y. P. AU - Zhu, Y. B. AU - Li, Q. AU - Chen, J. PY - 2013 DA - 2013// TI - Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer JO - Cancer Immunol Immunother VL - 62 UR - https://doi.org/10.1007/s00262-012-1358-6 DO - 10.1007/s00262-012-1358-6 ID - Chen2013 ER - TY - JOUR AU - Chaisemartin, L. AU - Goc, J. AU - Damotte, D. AU - Validire, P. AU - Magdeleinat, P. AU - Alifano, M. PY - 2011 DA - 2011// TI - Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-0952 DO - 10.1158/0008-5472.CAN-11-0952 ID - Chaisemartin2011 ER - TY - JOUR AU - Chew, V. AU - Chen, J. AU - Lee, D. AU - Loh, E. AU - Lee, J. AU - Lim, K. H. PY - 2012 DA - 2012// TI - Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma JO - Gut VL - 61 UR - https://doi.org/10.1136/gutjnl-2011-300509 DO - 10.1136/gutjnl-2011-300509 ID - Chew2012 ER - TY - JOUR AU - Chew, V. AU - Tow, C. AU - Teo, M. AU - Wong, H. L. AU - Chan, J. AU - Gehring, A. PY - 2010 DA - 2010// TI - Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients JO - J Hepatol VL - 52 UR - https://doi.org/10.1016/j.jhep.2009.07.013 DO - 10.1016/j.jhep.2009.07.013 ID - Chew2010 ER - TY - JOUR AU - Kondo, T. AU - Nakazawa, H. AU - Ito, F. AU - Hashimoto, Y. AU - Osaka, Y. AU - Futatsuyama, K. PY - 2006 DA - 2006// TI - Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response JO - Cancer Sci VL - 97 UR - https://doi.org/10.1111/j.1349-7006.2006.00231.x DO - 10.1111/j.1349-7006.2006.00231.x ID - Kondo2006 ER - TY - JOUR AU - Galon, J. AU - Mlecnik, B. AU - Bindea, G. AU - Angell, H. K. AU - Berger, A. AU - Lagorce, C. PY - 2014 DA - 2014// TI - Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours JO - J Pathol VL - 232 UR - https://doi.org/10.1002/path.4287 DO - 10.1002/path.4287 ID - Galon2014 ER - TY - JOUR AU - Galon, J. AU - Pages, F. AU - Marincola, F. M. AU - Angell, H. K. AU - Thurin, M. AU - Lugli, A. PY - 2012 DA - 2012// TI - Cancer classification using the Immunoscore: a worldwide task force JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-205 DO - 10.1186/1479-5876-10-205 ID - Galon2012 ER - TY - JOUR AU - Pages, F. AU - Kirilovsky, A. AU - Mlecnik, B. AU - Asslaber, M. AU - Tosolini, M. AU - Bindea, G. PY - 2009 DA - 2009// TI - In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.19.6147 DO - 10.1200/JCO.2008.19.6147 ID - Pages2009 ER - TY - JOUR AU - Pages, F. AU - Galon, J. AU - Dieu-Nosjean, M. C. AU - Tartour, E. AU - Sautes-Fridman, C. AU - Fridman, W. H. PY - 2010 DA - 2010// TI - Immune infiltration in human tumors: a prognostic factor that should not be ignored JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2009.416 DO - 10.1038/onc.2009.416 ID - Pages2010 ER - TY - JOUR AU - Dixon, A. R. AU - Bathany, C. AU - Tsuei, M. AU - White, J. AU - Barald, K. F. AU - Takayama, S. PY - 2015 DA - 2015// TI - Recent developments in multiplexing techniques for immunohistochemistry JO - Expert Rev Mol Diagn VL - 15 UR - https://doi.org/10.1586/14737159.2015.1069182 DO - 10.1586/14737159.2015.1069182 ID - Dixon2015 ER - TY - JOUR AU - Hollman-Hewgley, D. AU - Lazare, M. AU - Bordwell, A. AU - Zebadua, E. AU - Tripathi, P. AU - Ross, A. S. PY - 2014 DA - 2014// TI - A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma JO - Am J Surg Pathol VL - 38 UR - https://doi.org/10.1097/PAS.0000000000000242 DO - 10.1097/PAS.0000000000000242 ID - Hollman-Hewgley2014 ER - TY - JOUR AU - Remark, R. AU - Merghoub, T. AU - Grabe, N. AU - Litjens, G. AU - Damotte, D. AU - Wolchok, J. D. PY - 2016 DA - 2016// TI - In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide JO - Sci Immunol VL - 1 UR - https://doi.org/10.1126/sciimmunol.aaf6925 DO - 10.1126/sciimmunol.aaf6925 ID - Remark2016 ER - TY - JOUR AU - Messina, J. L. AU - Fenstermacher, D. A. AU - Eschrich, S. AU - Qu, X. AU - Berglund, A. E. AU - Lloyd, M. C. PY - 2012 DA - 2012// TI - 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? JO - Sci Rep VL - 2 UR - https://doi.org/10.1038/srep00765 DO - 10.1038/srep00765 ID - Messina2012 ER - TY - JOUR AU - Ascierto, P. A. AU - Kalos, M. AU - Schaer, D. A. AU - Callahan, M. K. AU - Wolchok, J. D. PY - 2013 DA - 2013// TI - Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2982 DO - 10.1158/1078-0432.CCR-12-2982 ID - Ascierto2013 ER - TY - JOUR AU - Ji, R. R. AU - Chasalow, S. D. AU - Wang, L. AU - Hamid, O. AU - Schmidt, H. AU - Cogswell, J. PY - 2012 DA - 2012// TI - An immune-active tumor microenvironment favors clinical response to ipilimumab JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1172-6 DO - 10.1007/s00262-011-1172-6 ID - Ji2012 ER - TY - JOUR AU - Taube, J. M. AU - Anders, R. A. AU - Young, G. D. AU - Xu, H. AU - Sharma, R. AU - McMiller, T. L. PY - 2012 DA - 2012// TI - Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003689 DO - 10.1126/scitranslmed.3003689 ID - Taube2012 ER - TY - JOUR AU - Vries, I. J. AU - Bernsen, M. R. AU - Geloof, W. L. AU - Scharenborg, N. M. AU - Lesterhuis, W. J. AU - Rombout, P. D. PY - 2007 DA - 2007// TI - In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients JO - Cancer Immunol Immunother VL - 56 UR - https://doi.org/10.1007/s00262-007-0304-5 DO - 10.1007/s00262-007-0304-5 ID - Vries2007 ER - TY - JOUR AU - Robins, H. S. AU - Campregher, P. V. AU - Srivastava, S. K. AU - Wacher, A. AU - Turtle, C. J. AU - Kahsai, O. PY - 2009 DA - 2009// TI - Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-04-217604 DO - 10.1182/blood-2009-04-217604 ID - Robins2009 ER - TY - JOUR AU - Nagalla, S. AU - Chou, J. W. AU - Willingham, M. C. AU - Ruiz, J. AU - Vaughn, J. P. AU - Dubey, P. PY - 2013 DA - 2013// TI - Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis JO - Genome Biol VL - 14 UR - https://doi.org/10.1186/gb-2013-14-4-r34 DO - 10.1186/gb-2013-14-4-r34 ID - Nagalla2013 ER - TY - JOUR AU - Rody, A. AU - Holtrich, U. AU - Pusztai, L. AU - Liedtke, C. AU - Gaetje, R. AU - Ruckhaeberle, E. PY - 2009 DA - 2009// TI - T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers JO - Breast Cancer Res VL - 11 UR - https://doi.org/10.1186/bcr2234 DO - 10.1186/bcr2234 ID - Rody2009 ER - TY - JOUR AU - Schmidt, M. AU - Bohm, D. AU - Torne, C. AU - Steiner, E. AU - Puhl, A. AU - Pilch, H. PY - 2008 DA - 2008// TI - The humoral immune system has a key prognostic impact in node-negative breast cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5206 DO - 10.1158/0008-5472.CAN-07-5206 ID - Schmidt2008 ER - TY - JOUR AU - Teschendorff, A. E. AU - Miremadi, A. AU - Pinder, S. E. AU - Ellis, I. O. AU - Caldas, C. PY - 2007 DA - 2007// TI - An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer JO - Genome Biol VL - 8 UR - https://doi.org/10.1186/gb-2007-8-8-r157 DO - 10.1186/gb-2007-8-8-r157 ID - Teschendorff2007 ER - TY - JOUR AU - Wang, E. AU - Miller, L. D. AU - Ohnmacht, G. A. AU - Mocellin, S. AU - Perez-Diez, A. AU - Petersen, D. PY - 2002 DA - 2002// TI - Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness JO - Cancer Res VL - 62 ID - Wang2002 ER - TY - JOUR AU - Bianchini, G. AU - Qi, Y. AU - Alvarez, R. H. AU - Iwamoto, T. AU - Coutant, C. AU - Ibrahim, N. K. PY - 2010 DA - 2010// TI - Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.2419 DO - 10.1200/JCO.2009.27.2419 ID - Bianchini2010 ER - TY - JOUR AU - Kreike, B. AU - Kouwenhove, M. AU - Horlings, H. AU - Weigelt, B. AU - Peterse, H. AU - Bartelink, H. PY - 2007 DA - 2007// TI - Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas JO - Breast Cancer Res VL - 9 UR - https://doi.org/10.1186/bcr1771 DO - 10.1186/bcr1771 ID - Kreike2007 ER - TY - JOUR AU - Rody, A. AU - Karn, T. AU - Liedtke, C. AU - Pusztai, L. AU - Ruckhaeberle, E. AU - Hanker, L. PY - 2011 DA - 2011// TI - A clinically relevant gene signature in triple negative and basal-like breast cancer JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr3035 DO - 10.1186/bcr3035 ID - Rody2011 ER - TY - JOUR AU - Teschendorff, A. E. AU - Gomez, S. AU - Arenas, A. AU - El-Ashry, D. AU - Schmidt, M. AU - Gehrmann, M. PY - 2010 DA - 2010// TI - Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-604 DO - 10.1186/1471-2407-10-604 ID - Teschendorff2010 ER - TY - JOUR AU - Alistar, A. AU - Chou, J. W. AU - Nagalla, S. AU - Black, M. A. AU - D’Agostino, R. AU - Miller, L. D. PY - 2014 DA - 2014// TI - Dual roles for immune metagenes in breast cancer prognosis and therapy prediction JO - Genome Med VL - 6 UR - https://doi.org/10.1186/s13073-014-0080-8 DO - 10.1186/s13073-014-0080-8 ID - Alistar2014 ER - TY - JOUR AU - Denkert, C. AU - Minckwitz, G. AU - Brase, J. C. AU - Sinn, B. V. AU - Gade, S. AU - Kronenwett, R. PY - 2015 DA - 2015// TI - Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.1967 DO - 10.1200/JCO.2014.58.1967 ID - Denkert2015 ER - TY - JOUR AU - Ignatiadis, M. AU - Singhal, S. K. AU - Desmedt, C. AU - Haibe-Kains, B. AU - Criscitiello, C. AU - Andre, F. PY - 2012 DA - 2012// TI - Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.5624 DO - 10.1200/JCO.2011.39.5624 ID - Ignatiadis2012 ER - TY - JOUR AU - Karn, T. AU - Pusztai, L. AU - Holtrich, U. AU - Iwamoto, T. AU - Shiang, C. Y. AU - Schmidt, M. PY - 2011 DA - 2011// TI - Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0028403 DO - 10.1371/journal.pone.0028403 ID - Karn2011 ER - TY - JOUR AU - Stoll, G. AU - Enot, D. AU - Mlecnik, B. AU - Galon, J. AU - Zitvogel, L. AU - Kroemer, G. PY - 2014 DA - 2014// TI - Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy JO - Oncoimmunology VL - 3 UR - https://doi.org/10.4161/onci.27884 DO - 10.4161/onci.27884 ID - Stoll2014 ER - TY - JOUR AU - Bindea, G. AU - Mlecnik, B. AU - Tosolini, M. AU - Kirilovsky, A. AU - Waldner, M. AU - Obenauf, A. C. PY - 2013 DA - 2013// TI - Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer JO - Immunity VL - 39 UR - https://doi.org/10.1016/j.immuni.2013.10.003 DO - 10.1016/j.immuni.2013.10.003 ID - Bindea2013 ER - TY - JOUR AU - Mlecnik, B. AU - Bindea, G. AU - Kirilovsky, A. AU - Angell, H. K. AU - Obenauf, A. C. AU - Tosolini, M. PY - 2016 DA - 2016// TI - The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aad6352 DO - 10.1126/scitranslmed.aad6352 ID - Mlecnik2016 ER - TY - JOUR AU - Cirenajwis, H. AU - Ekedahl, H. AU - Lauss, M. AU - Harbst, K. AU - Carneiro, A. AU - Enoksson, J. PY - 2015 DA - 2015// TI - Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3655 DO - 10.18632/oncotarget.3655 ID - Cirenajwis2015 ER - TY - JOUR AU - Ulloa-Montoya, F. AU - Louahed, J. AU - Dizier, B. AU - Gruselle, O. AU - Spiessens, B. AU - Lehmann, F. F. PY - 2013 DA - 2013// TI - Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.3762 DO - 10.1200/JCO.2012.44.3762 ID - Ulloa-Montoya2013 ER - TY - JOUR AU - Gyorffy, B. AU - Hatzis, C. AU - Sanft, T. AU - Hofstatter, E. AU - Aktas, B. AU - Pusztai, L. PY - 2015 DA - 2015// TI - Multigene prognostic tests in breast cancer: past, present, future JO - Breast Cancer Res VL - 17 UR - https://doi.org/10.1186/s13058-015-0514-2 DO - 10.1186/s13058-015-0514-2 ID - Gyorffy2015 ER - TY - JOUR AU - Ross, J. S. AU - Hatzis, C. AU - Symmans, W. F. AU - Pusztai, L. AU - Hortobagyi, G. N. PY - 2008 DA - 2008// TI - Commercialized multigene predictors of clinical outcome for breast cancer JO - Oncologist VL - 13 UR - https://doi.org/10.1634/theoncologist.2007-0248 DO - 10.1634/theoncologist.2007-0248 ID - Ross2008 ER - TY - JOUR AU - Yoshihara, K. AU - Shahmoradgoli, M. AU - Martinez, E. AU - Vegesna, R. AU - Kim, H. AU - Torres-Garcia, W. PY - 2013 DA - 2013// TI - Inferring tumour purity and stromal and immune cell admixture from expression data JO - Nat Commun VL - 4 UR - https://doi.org/10.1038/ncomms3612 DO - 10.1038/ncomms3612 ID - Yoshihara2013 ER - TY - JOUR AU - Gentles, A. J. AU - Newman, A. M. AU - Liu, C. L. AU - Bratman, S. V. AU - Feng, W. AU - Kim, D. PY - 2015 DA - 2015// TI - The prognostic landscape of genes and infiltrating immune cells across human cancers JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3909 DO - 10.1038/nm.3909 ID - Gentles2015 ER - TY - JOUR AU - Newman, A. M. AU - Liu, C. L. AU - Green, M. R. AU - Gentles, A. J. AU - Feng, W. AU - Xu, Y. PY - 2015 DA - 2015// TI - Robust enumeration of cell subsets from tissue expression profiles JO - Nat Methods VL - 12 UR - https://doi.org/10.1038/nmeth.3337 DO - 10.1038/nmeth.3337 ID - Newman2015 ER - TY - JOUR AU - Snyder, A. AU - Makarov, V. AU - Merghoub, T. AU - Yuan, J. AU - Zaretsky, J. M. AU - Desrichard, A. PY - 2014 DA - 2014// TI - Genetic basis for clinical response to CTLA-4 blockade in melanoma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1406498 DO - 10.1056/NEJMoa1406498 ID - Snyder2014 ER - TY - JOUR AU - Rizvi, N. A. AU - Hellmann, M. D. AU - Snyder, A. AU - Kvistborg, P. AU - Makarov, V. AU - Havel, J. J. PY - 2015 DA - 2015// TI - Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa1348 DO - 10.1126/science.aaa1348 ID - Rizvi2015 ER - TY - JOUR AU - Le, D. T. AU - Uram, J. N. AU - Wang, H. AU - Bartlett, B. R. AU - Kemberling, H. AU - Eyring, A. D. PY - 2015 DA - 2015// TI - PD-1 Blockade in Tumors with Mismatch-Repair Deficiency JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1500596 DO - 10.1056/NEJMoa1500596 ID - Le2015 ER - TY - JOUR AU - Ansell, S. M. AU - Lesokhin, A. M. AU - Borrello, I. AU - Halwani, A. AU - Scott, E. C. AU - Gutierrez, M. PY - 2015 DA - 2015// TI - PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1411087 DO - 10.1056/NEJMoa1411087 ID - Ansell2015 ER - TY - JOUR AU - Koster, B. D. AU - Gruijl, T. D. AU - Eertwegh, A. J. PY - 2015 DA - 2015// TI - Recent developments and future challenges in immune checkpoint inhibitory cancer treatment JO - Curr Opin Oncol VL - 27 UR - https://doi.org/10.1097/CCO.0000000000000221 DO - 10.1097/CCO.0000000000000221 ID - Koster2015 ER - TY - JOUR AU - Garon, E. B. AU - Rizvi, N. A. AU - Hui, R. AU - Leighl, N. AU - Balmanoukian, A. S. AU - Eder, J. P. PY - 2015 DA - 2015// TI - Pembrolizumab for the treatment of non-small-cell lung cancer JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1501824 DO - 10.1056/NEJMoa1501824 ID - Garon2015 ER - TY - JOUR AU - Meyskens, F. L. AU - Kopecky, K. AU - Samson, M. AU - Hersh, E. AU - Macdonald, J. AU - Jaffe, H. PY - 1990 DA - 1990// TI - Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma JO - J Natl Cancer Inst VL - 82 UR - https://doi.org/10.1093/jnci/82.12.1071-a DO - 10.1093/jnci/82.12.1071-a ID - Meyskens1990 ER - TY - JOUR AU - Schumacher, T. N. AU - Schreiber, R. D. PY - 2015 DA - 2015// TI - Neoantigens in cancer immunotherapy JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa4971 DO - 10.1126/science.aaa4971 ID - Schumacher2015 ER - TY - JOUR AU - Mlecnik, B. AU - Bindea, G. AU - Angell, H. K. AU - Maby, P. AU - Angelova, M. AU - Tougeron, D. PY - 2016 DA - 2016// TI - Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability JO - Immunity VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.02.025 DO - 10.1016/j.immuni.2016.02.025 ID - Mlecnik2016 ER - TY - JOUR AU - Church, S. E. AU - Galon, J. PY - 2015 DA - 2015// TI - Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a Glimpse JO - Immunity VL - 43 UR - https://doi.org/10.1016/j.immuni.2015.10.004 DO - 10.1016/j.immuni.2015.10.004 ID - Church2015 ER - TY - JOUR AU - Vigneron, N. AU - Stroobant, V. AU - Chapiro, J. AU - Ooms, A. AU - Degiovanni, G. AU - Morel, S. PY - 2004 DA - 2004// TI - An antigenic peptide produced by peptide splicing in the proteasome JO - Science VL - 304 UR - https://doi.org/10.1126/science.1095522 DO - 10.1126/science.1095522 ID - Vigneron2004 ER - TY - JOUR AU - Madsen, C. B. AU - Petersen, C. AU - Lavrsen, K. AU - Harndahl, M. AU - Buus, S. AU - Clausen, H. PY - 2012 DA - 2012// TI - Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0050139 DO - 10.1371/journal.pone.0050139 ID - Madsen2012 ER - TY - JOUR AU - Cobbold, M. AU - Pena, H. AU - Norris, A. AU - Polefrone, J. M. AU - Qian, J. AU - English, A. M. PY - 2013 DA - 2013// TI - MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006061 DO - 10.1126/scitranslmed.3006061 ID - Cobbold2013 ER - TY - JOUR AU - Angelova, M. AU - Charoentong, P. AU - Hackl, H. AU - Fischer, M. L. AU - Snajder, R. AU - Krogsdam, A. M. PY - 2015 DA - 2015// TI - Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy JO - Genome Biol VL - 16 UR - https://doi.org/10.1186/s13059-015-0620-6 DO - 10.1186/s13059-015-0620-6 ID - Angelova2015 ER - TY - JOUR AU - Lim, C. AU - Tsao, M. S. AU - Le, L. W. AU - Shepherd, F. A. AU - Feld, R. AU - Burkes, R. L. PY - 2015 DA - 2015// TI - Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv208 DO - 10.1093/annonc/mdv208 ID - Lim2015 ER - TY - JOUR AU - Iero, M. AU - Valenti, R. AU - Huber, V. AU - Filipazzi, P. AU - Parmiani, G. AU - Fais, S. PY - 2008 DA - 2008// TI - Tumour-released exosomes and their implications in cancer immunity JO - Cell Death Differ VL - 15 UR - https://doi.org/10.1038/sj.cdd.4402237 DO - 10.1038/sj.cdd.4402237 ID - Iero2008 ER - TY - JOUR AU - Kirkwood, J. M. AU - Lee, S. AU - Moschos, S. J. AU - Albertini, M. R. AU - Michalak, J. C. AU - Sander, C. PY - 2009 DA - 2009// TI - Immunogenicity and antitumor effects of vaccination with peptide vaccine+/−granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696 JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1231 DO - 10.1158/1078-0432.CCR-08-1231 ID - Kirkwood2009 ER - TY - JOUR AU - Schaefer, C. AU - Butterfield, L. H. AU - Lee, S. AU - Kim, G. G. AU - Visus, C. AU - Albers, A. PY - 2012 DA - 2012// TI - Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696) JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.26481 DO - 10.1002/ijc.26481 ID - Schaefer2012 ER - TY - JOUR AU - Czystowska, M. AU - Gooding, W. AU - Szczepanski, M. J. AU - Lopez-Abaitero, A. AU - Ferris, R. L. AU - Johnson, J. T. PY - 2013 DA - 2013// TI - The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2191 DO - 10.1158/1078-0432.CCR-12-2191 ID - Czystowska2013 ER - TY - JOUR AU - Whiteside, T. L. PY - 2012 DA - 2012// TI - What are regulatory T cells (Treg) regulating in cancer and why? JO - Semin Cancer Biol VL - 22 UR - https://doi.org/10.1016/j.semcancer.2012.03.004 DO - 10.1016/j.semcancer.2012.03.004 ID - Whiteside2012 ER - TY - JOUR AU - Lippitz, B. E. PY - 2013 DA - 2013// TI - Cytokine patterns in patients with cancer: a systematic review JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(12)70582-X DO - 10.1016/S1470-2045(12)70582-X ID - Lippitz2013 ER - TY - JOUR AU - Lin, S. AU - Gregory, R. I. PY - 2015 DA - 2015// TI - MicroRNA biogenesis pathways in cancer JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc3932 DO - 10.1038/nrc3932 ID - Lin2015 ER - TY - JOUR AU - Maker, A. V. AU - Attia, P. AU - Rosenberg, S. A. PY - 2005 DA - 2005// TI - Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.11.7746 DO - 10.4049/jimmunol.175.11.7746 ID - Maker2005 ER - TY - JOUR AU - Yuan, J. AU - Gnjatic, S. AU - Li, H. AU - Powel, S. AU - Gallardo, H. F. AU - Ritter, E. PY - 2008 DA - 2008// TI - CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0810114105 DO - 10.1073/pnas.0810114105 ID - Yuan2008 ER - TY - JOUR AU - Liakou, C. I. AU - Kamat, A. AU - Tang, D. N. AU - Chen, H. AU - Sun, J. AU - Troncoso, P. PY - 2008 DA - 2008// TI - CTLA-4 blockade increases IFNgamma-producing CD4 + ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0806075105 DO - 10.1073/pnas.0806075105 ID - Liakou2008 ER - TY - JOUR AU - Bendall, S. C. AU - Simonds, E. F. AU - Qiu, P. AU - Amir, A. D. AU - Krutzik, P. O. AU - Finck, R. PY - 2011 DA - 2011// TI - Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum JO - Science VL - 332 UR - https://doi.org/10.1126/science.1198704 DO - 10.1126/science.1198704 ID - Bendall2011 ER - TY - JOUR AU - Proserpio, V. AU - Lonnberg, T. PY - 2016 DA - 2016// TI - Single-cell technologies are revolutionizing the approach to rare cells JO - Immunol Cell Biol VL - 94 UR - https://doi.org/10.1038/icb.2015.106 DO - 10.1038/icb.2015.106 ID - Proserpio2016 ER - TY - JOUR AU - Horowitz, A. AU - Strauss-Albee, D. M. AU - Leipold, M. AU - Kubo, J. AU - Nemat-Gorgani, N. AU - Dogan, O. C. PY - 2013 DA - 2013// TI - Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006702 DO - 10.1126/scitranslmed.3006702 ID - Horowitz2013 ER - TY - JOUR AU - Han, A. AU - Newell, E. W. AU - Glanville, J. AU - Fernandez-Becker, N. AU - Khosla, C. AU - Chien, Y. H. PY - 2013 DA - 2013// TI - Dietary gluten triggers concomitant activation of CD4+ and CD8+ alphabeta T cells and gammadelta T cells in celiac disease JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1311861110 DO - 10.1073/pnas.1311861110 ID - Han2013 ER - TY - JOUR AU - Maecker, H. T. AU - Harari, A. PY - 2015 DA - 2015// TI - Immune monitoring technology primer: flow and mass cytometry JO - J Immunother Cancer VL - 3 UR - https://doi.org/10.1186/s40425-015-0085-x DO - 10.1186/s40425-015-0085-x ID - Maecker2015 ER - TY - JOUR AU - Diaz-Montero, C. M. AU - Finke, J. AU - Montero, A. J. PY - 2014 DA - 2014// TI - Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications JO - Semin Oncol VL - 41 UR - https://doi.org/10.1053/j.seminoncol.2014.02.003 DO - 10.1053/j.seminoncol.2014.02.003 ID - Diaz-Montero2014 ER - TY - JOUR AU - Farsaci, B. AU - Donahue, R. N. AU - Grenga, I. AU - Lepone, L. M. AU - Kim, P. S. AU - Dempsey, B. PY - 2016 DA - 2016// TI - Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy JO - Cancer Immunol Res VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-16-0037 DO - 10.1158/2326-6066.CIR-16-0037 ID - Farsaci2016 ER - TY - JOUR AU - Gros, A. AU - Parkhurst, M. R. AU - Tran, E. AU - Pasetto, A. AU - Robbins, P. F. AU - Ilyas, S. PY - 2016 DA - 2016// TI - Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4051 DO - 10.1038/nm.4051 ID - Gros2016 ER - TY - JOUR AU - Rooij, N. AU - Buuren, M. M. AU - Philips, D. AU - Velds, A. AU - Toebes, M. AU - Heemskerk, B. PY - 2013 DA - 2013// TI - Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.47.7521 DO - 10.1200/JCO.2012.47.7521 ID - Rooij2013 ER - TY - JOUR AU - Butler, M. O. AU - Friedlander, P. AU - Milstein, M. I. AU - Mooney, M. M. AU - Metzler, G. AU - Murray, A. P. PY - 2011 DA - 2011// TI - Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3002207 DO - 10.1126/scitranslmed.3002207 ID - Butler2011 ER - TY - JOUR AU - Powell, D. J. AU - Dudley, M. E. AU - Robbins, P. F. AU - Rosenberg, S. A. PY - 2005 DA - 2005// TI - Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-06-2482 DO - 10.1182/blood-2004-06-2482 ID - Powell2005 ER - TY - JOUR AU - Ochsenbein, A. F. AU - Riddell, S. R. AU - Brown, M. AU - Corey, L. AU - Baerlocher, G. M. AU - Lansdorp, P. M. PY - 2004 DA - 2004// TI - CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients JO - J Exp Med VL - 200 UR - https://doi.org/10.1084/jem.20040717 DO - 10.1084/jem.20040717 ID - Ochsenbein2004 ER - TY - JOUR AU - MacFarlane, A. W. AU - Jillab, M. AU - Plimack, E. R. AU - Hudes, G. R. AU - Uzzo, R. G. AU - Litwin, S. PY - 2014 DA - 2014// TI - PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-13-0133 DO - 10.1158/2326-6066.CIR-13-0133 ID - MacFarlane2014 ER - TY - JOUR AU - Dronca, R. S. AU - Markovic, S. AU - Kottschade, L. A. AU - McWilliams, R. R. AU - Block, M. S. AU - Nevala, W. K. PY - 2015 DA - 2015// TI - Bim as a predictive T-cell biomarker for response to anti-PD-1 therapy in metastatic melanoma (MM) JO - ASCO Meeting Abstracts VL - 33 ID - Dronca2015 ER - TY - JOUR AU - Cha, E. AU - Klinger, M. AU - Hou, Y. AU - Cummings, C. AU - Ribas, A. AU - Faham, M. PY - 2014 DA - 2014// TI - Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3008211 DO - 10.1126/scitranslmed.3008211 ID - Cha2014 ER - TY - JOUR AU - Gajewski, T. F. AU - Schreiber, H. AU - Fu, Y. X. PY - 2013 DA - 2013// TI - Innate and adaptive immune cells in the tumor microenvironment JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2703 DO - 10.1038/ni.2703 ID - Gajewski2013 ER - TY - JOUR AU - Lynch, H. E. AU - Sanchez, A. M. AU - D’Souza, M. P. AU - Rountree, W. AU - Denny, T. N. AU - Kalos, M. PY - 2014 DA - 2014// TI - Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays JO - J Immunol Methods VL - 409 UR - https://doi.org/10.1016/j.jim.2014.04.011 DO - 10.1016/j.jim.2014.04.011 ID - Lynch2014 ER - TY - JOUR AU - Brunet, L. R. AU - LaBrie, S. AU - Hagemann, T. PY - 2016 DA - 2016// TI - Immune monitoring technology primer: immunoprofiling of antigen-stimulated blood JO - J Immunother Cancer VL - 4 UR - https://doi.org/10.1186/s40425-016-0122-4 DO - 10.1186/s40425-016-0122-4 ID - Brunet2016 ER - TY - JOUR AU - Mueller, S. C. AU - Marz, R. AU - Schmolz, M. AU - Drewelow, B. PY - 2012 DA - 2012// TI - Intraindividual long term stability and response corridors of cytokines in healthy volunteers detected by a standardized whole-blood culture system for bed-side application JO - BMC Med Res Methodol VL - 12 UR - https://doi.org/10.1186/1471-2288-12-112 DO - 10.1186/1471-2288-12-112 ID - Mueller2012 ER - TY - JOUR AU - Duffy, D. AU - Rouilly, V. AU - Libri, V. AU - Hasan, M. AU - Beitz, B. AU - David, M. PY - 2014 DA - 2014// TI - Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli JO - Immunity VL - 40 UR - https://doi.org/10.1016/j.immuni.2014.03.002 DO - 10.1016/j.immuni.2014.03.002 ID - Duffy2014 ER - TY - JOUR AU - Dietsch, G. N. AU - Lu, H. AU - Yang, Y. AU - Morishima, C. AU - Chow, L. Q. AU - Disis, M. L. PY - 2016 DA - 2016// TI - Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0148764 DO - 10.1371/journal.pone.0148764 ID - Dietsch2016 ER - TY - JOUR AU - Lerman, I. AU - Hauger, R. AU - Sorkin, L. AU - Proudfoot, J. AU - Davis, B. AU - Huang, A. PY - 2016 DA - 2016// TI - Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial JO - Neuromodulation VL - 19 UR - https://doi.org/10.1111/ner.12398 DO - 10.1111/ner.12398 ID - Lerman2016 ER - TY - JOUR AU - Herberth, M. AU - Rahmoune, H. AU - Schwarz, E. AU - Koethe, D. AU - Harris, L. W. AU - Kranaster, L. PY - 2014 DA - 2014// TI - Identification of a molecular profile associated with immune status in first-onset schizophrenia patients JO - Clin Schizophr Relat Psychoses VL - 7 UR - https://doi.org/10.3371/CSRP.HERA.020113 DO - 10.3371/CSRP.HERA.020113 ID - Herberth2014 ER - TY - JOUR AU - Messaoudi, I. AU - Guevara Patino, J. A. AU - Dyall, R. AU - LeMaoult, J. AU - Nikolich-Zugich, J. PY - 2002 DA - 2002// TI - Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense JO - Science VL - 298 UR - https://doi.org/10.1126/science.1076064 DO - 10.1126/science.1076064 ID - Messaoudi2002 ER - TY - JOUR AU - Davenport, M. P. AU - Price, D. A. AU - McMichael, A. J. PY - 2007 DA - 2007// TI - The T cell repertoire in infection and vaccination: implications for control of persistent viruses JO - Curr Opin Immunol VL - 19 UR - https://doi.org/10.1016/j.coi.2007.04.001 DO - 10.1016/j.coi.2007.04.001 ID - Davenport2007 ER - TY - JOUR AU - Chen, H. AU - Ndhlovu, Z. M. AU - Liu, D. AU - Porter, L. C. AU - Fang, J. W. AU - Darko, S. PY - 2012 DA - 2012// TI - TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection JO - Nat Immunol VL - 13 UR - https://doi.org/10.1038/ni.2342 DO - 10.1038/ni.2342 ID - Chen2012 ER - TY - JOUR AU - Bolotin, D. A. AU - Mamedov, I. Z. AU - Britanova, O. V. AU - Zvyagin, I. V. AU - Shagin, D. AU - Ustyugova, S. V. PY - 2012 DA - 2012// TI - Next generation sequencing for TCR repertoire profiling: platform-specific features and correction algorithms JO - Eur J Immunol VL - 42 UR - https://doi.org/10.1002/eji.201242517 DO - 10.1002/eji.201242517 ID - Bolotin2012 ER - TY - JOUR AU - Robert, L. AU - Tsoi, J. AU - Wang, X. AU - Emerson, R. AU - Homet, B. AU - Chodon, T. PY - 2014 DA - 2014// TI - CTLA4 blockade broadens the peripheral T-cell receptor repertoire JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2648 DO - 10.1158/1078-0432.CCR-13-2648 ID - Robert2014 ER - TY - JOUR AU - Postow, M. A. AU - Manuel, M. AU - Wong, P. AU - Yuan, J. AU - Dong, Z. AU - Liu, C. PY - 2015 DA - 2015// TI - Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma JO - J Immunother Cancer VL - 3 UR - https://doi.org/10.1186/s40425-015-0070-4 DO - 10.1186/s40425-015-0070-4 ID - Postow2015 ER - TY - JOUR AU - Robert, L. AU - Harview, C. AU - Emerson, R. AU - Wang, X. AU - Mok, S. AU - Homet, B. PY - 2014 DA - 2014// TI - Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes JO - Oncoimmunology VL - 3 UR - https://doi.org/10.4161/onci.29244 DO - 10.4161/onci.29244 ID - Robert2014 ER - TY - JOUR AU - Nagata, Y. AU - Ono, S. AU - Matsuo, M. AU - Gnjatic, S. AU - Valmori, D. AU - Ritter, G. PY - 2002 DA - 2002// TI - Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations JO - Proc Natl Acad Sci U S A VL - 99 UR - https://doi.org/10.1073/pnas.112331099 DO - 10.1073/pnas.112331099 ID - Nagata2002 ER - TY - JOUR AU - Gnjatic, S. AU - Atanackovic, D. AU - Jäger, E. AU - Matsuo, M. AU - Selvakumar, A. AU - Altorki, N. K. PY - 2003 DA - 2003// TI - Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1133324100 DO - 10.1073/pnas.1133324100 ID - Gnjatic2003 ER - TY - JOUR AU - Noguchi, T. AU - Kato, T. AU - Wang, L. AU - Maeda, Y. AU - Ikeda, H. AU - Sato, E. PY - 2012 DA - 2012// TI - Intracellular tumor-associated antigens represent effective targets for passive immunotherapy JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3072 DO - 10.1158/0008-5472.CAN-11-3072 ID - Noguchi2012 ER - TY - JOUR AU - Yuan, J. AU - Adamow, M. AU - Ginsberg, B. A. AU - Rasalan, T. S. AU - Ritter, E. AU - Gallardo, H. F. PY - 2011 DA - 2011// TI - Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1110814108 DO - 10.1073/pnas.1110814108 ID - Yuan2011 ER - TY - JOUR AU - Germain, C. AU - Gnjatic, S. AU - Dieu-Nosjean, M. C. PY - 2015 DA - 2015// TI - Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity JO - Front Immunol VL - 6 UR - https://doi.org/10.3389/fimmu.2015.00067 DO - 10.3389/fimmu.2015.00067 ID - Germain2015 ER - TY - JOUR AU - Germain, C. AU - Gnjatic, S. AU - Tamzalit, F. AU - Knockaert, S. AU - Remark, R. AU - Goc, J. PY - 2014 DA - 2014// TI - Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer JO - Am J Respir Crit Care Med VL - 189 UR - https://doi.org/10.1164/rccm.201309-1611OC DO - 10.1164/rccm.201309-1611OC ID - Germain2014 ER - TY - JOUR AU - Dieu-Nosjean, M. C. AU - Antoine, M. AU - Danel, C. AU - Heudes, D. AU - Wislez, M. AU - Poulot, V. PY - 2008 DA - 2008// TI - Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.0284 DO - 10.1200/JCO.2007.15.0284 ID - Dieu-Nosjean2008 ER - TY - JOUR AU - Schrama, D. AU - Voigt, H. AU - Eggert, A. O. AU - Xiang, R. AU - Zhou, H. AU - Schumacher, T. N. PY - 2008 DA - 2008// TI - Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue JO - Cancer Immunol Immunother VL - 57 UR - https://doi.org/10.1007/s00262-007-0352-x DO - 10.1007/s00262-007-0352-x ID - Schrama2008 ER - TY - JOUR AU - Damuzzo, V. AU - Pinton, L. AU - Desantis, G. AU - Solito, S. AU - Marigo, I. AU - Bronte, V. PY - 2015 DA - 2015// TI - Complexity and challenges in defining myeloid-derived suppressor cells JO - Cytometry B Clin Cytom VL - 88 UR - https://doi.org/10.1002/cyto.b.21206 DO - 10.1002/cyto.b.21206 ID - Damuzzo2015 ER - TY - JOUR AU - Gabitass, R. F. AU - Annels, N. E. AU - Stocken, D. D. AU - Pandha, H. A. AU - Middleton, G. W. PY - 2011 DA - 2011// TI - Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 JO - Cancer Immunol Immunother VL - 60 UR - https://doi.org/10.1007/s00262-011-1028-0 DO - 10.1007/s00262-011-1028-0 ID - Gabitass2011 ER - TY - JOUR AU - Kitano, S. AU - Postow, M. A. AU - Ziegler, C. G. AU - Kuk, D. AU - Panageas, K. S. AU - Cortez, C. PY - 2014 DA - 2014// TI - Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-14-0013 DO - 10.1158/2326-6066.CIR-14-0013 ID - Kitano2014 ER - TY - JOUR AU - Bronte, V. AU - Brandau, S. AU - Chen, S. H. AU - Colombo, M. P. AU - Frey, A. B. AU - Greten, T. F. PY - 2016 DA - 2016// TI - Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms12150 DO - 10.1038/ncomms12150 ID - Bronte2016 ER - TY - JOUR AU - Walter, S. AU - Weinschenk, T. AU - Stenzl, A. AU - Zdrojowy, R. AU - Pluzanska, A. AU - Szczylik, C. PY - 2012 DA - 2012// TI - Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2883 DO - 10.1038/nm.2883 ID - Walter2012 ER - TY - JOUR AU - Meyer, C. AU - Cagnon, L. AU - Costa-Nunes, C. M. AU - Baumgaertner, P. AU - Montandon, N. AU - Leyvraz, L. PY - 2014 DA - 2014// TI - Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-013-1508-5 DO - 10.1007/s00262-013-1508-5 ID - Meyer2014 ER - TY - JOUR AU - Tarhini, A. A. AU - Edington, H. AU - Butterfield, L. H. AU - Lin, Y. AU - Shuai, Y. AU - Tawbi, H. PY - 2014 DA - 2014// TI - Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0087705 DO - 10.1371/journal.pone.0087705 ID - Tarhini2014 ER - TY - STD TI - Mandruzzato S, Brandau S, Britten CM, Bronte V, Damuzzo V, Gouttefangeas C, et al.: Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study. Cancer Immunol Immunother 2016, in press. ID - ref155 ER - TY - JOUR AU - Kirkwood, J. M. AU - Ibrahim, J. G. AU - Sondak, V. K. AU - Richards, J. AU - Flaherty, L. E. AU - Ernstoff, M. S. PY - 2000 DA - 2000// TI - High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190 JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.12.2444 DO - 10.1200/JCO.2000.18.12.2444 ID - Kirkwood2000 ER - TY - JOUR AU - Kirkwood, J. M. AU - Manola, J. AU - Ibrahim, J. AU - Sondak, V. AU - Ernstoff, M. S. AU - Rao, U. PY - 2004 DA - 2004// TI - A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-1103-3 DO - 10.1158/1078-0432.CCR-1103-3 ID - Kirkwood2004 ER - TY - JOUR AU - Kirkwood, J. M. AU - Strawderman, M. H. AU - Ernstoff, M. S. AU - Smith, T. J. AU - Borden, E. C. AU - Blum, R. H. PY - 1996 DA - 1996// TI - Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684 JO - J Clin Oncol VL - 14 UR - https://doi.org/10.1200/JCO.1996.14.1.7 DO - 10.1200/JCO.1996.14.1.7 ID - Kirkwood1996 ER - TY - JOUR AU - Mocellin, S. AU - Lens, M. B. AU - Pasquali, S. AU - Pilati, P. AU - Chiarion Sileni, V. PY - 2013 DA - 2013// TI - Interferon alpha for the adjuvant treatment of cutaneous melanoma JO - Cochrane Database Syst Rev VL - 6 ID - Mocellin2013 ER - TY - JOUR AU - Yurkovetsky, Z. R. AU - Kirkwood, J. M. AU - Edington, H. D. AU - Marrangoni, A. M. AU - Velikokhatnaya, L. AU - Winans, M. T. PY - 2007 DA - 2007// TI - Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1805 DO - 10.1158/1078-0432.CCR-06-1805 ID - Yurkovetsky2007 ER - TY - JOUR AU - Gogas, H. AU - Ioannovich, J. AU - Dafni, U. AU - Stavropoulou-Giokas, C. AU - Frangia, K. AU - Tsoutsos, D. PY - 2006 DA - 2006// TI - Prognostic significance of autoimmunity during treatment of melanoma with interferon JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMoa053007 DO - 10.1056/NEJMoa053007 ID - Gogas2006 ER - TY - JOUR AU - Bouwhuis, M. G. AU - Suciu, S. AU - Collette, S. AU - Aamdal, S. AU - Kruit, W. H. AU - Bastholt, L. PY - 2009 DA - 2009// TI - Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp132 DO - 10.1093/jnci/djp132 ID - Bouwhuis2009 ER - TY - JOUR AU - Tarhini, A. A. AU - Stuckert, J. AU - Lee, S. AU - Sander, C. AU - Kirkwood, J. M. PY - 2009 DA - 2009// TI - Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694 JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.1777 DO - 10.1200/JCO.2008.17.1777 ID - Tarhini2009 ER - TY - JOUR AU - Lawson, D. H. AU - Lee, S. AU - Zhao, F. AU - Tarhini, A. A. AU - Margolin, K. A. AU - Ernstoff, M. S. PY - 2015 DA - 2015// TI - Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697) JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.62.0500 DO - 10.1200/JCO.2015.62.0500 ID - Lawson2015 ER - TY - JOUR AU - Eggermont, A. M. AU - Chiarion-Sileni, V. AU - Grob, J. J. AU - Dummer, R. AU - Wolchok, J. D. AU - Schmidt, H. PY - 2016 DA - 2016// TI - Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1611299 DO - 10.1056/NEJMoa1611299 ID - Eggermont2016 ER - TY - JOUR AU - Pe’er, I. AU - Bakker, P. I. AU - Maller, J. AU - Yelensky, R. AU - Altshuler, D. AU - Daly, M. J. PY - 2006 DA - 2006// TI - Evaluating and improving power in whole-genome association studies using fixed marker sets JO - Nat Genet VL - 38 UR - https://doi.org/10.1038/ng1816 DO - 10.1038/ng1816 ID - Pe’er2006 ER - TY - JOUR AU - Orru, V. AU - Steri, M. AU - Sole, G. AU - Sidore, C. AU - Virdis, F. AU - Dei, M. PY - 2013 DA - 2013// TI - Genetic variants regulating immune cell levels in health and disease JO - Cell VL - 155 UR - https://doi.org/10.1016/j.cell.2013.08.041 DO - 10.1016/j.cell.2013.08.041 ID - Orru2013 ER - TY - JOUR AU - Ye, C. J. AU - Feng, T. AU - Kwon, H. K. AU - Raj, T. AU - Wilson, M. T. AU - Asinovski, N. PY - 2014 DA - 2014// TI - Intersection of population variation and autoimmunity genetics in human T cell activation JO - Science VL - 345 UR - https://doi.org/10.1126/science.1254665 DO - 10.1126/science.1254665 ID - Ye2014 ER - TY - JOUR AU - Yucesoy, B. AU - Talzhanov, Y. AU - Johnson, V. J. AU - Wilson, N. W. AU - Biagini, R. E. AU - Wang, W. PY - 2013 DA - 2013// TI - Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2013.09.026 DO - 10.1016/j.vaccine.2013.09.026 ID - Yucesoy2013 ER - TY - JOUR AU - Kennedy, R. B. AU - Ovsyannikova, I. G. AU - Haralambieva, I. H. AU - Lambert, N. D. AU - Pankratz, V. S. AU - Poland, G. A. PY - 2014 DA - 2014// TI - Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients JO - Immunogenetics VL - 66 UR - https://doi.org/10.1007/s00251-014-0776-3 DO - 10.1007/s00251-014-0776-3 ID - Kennedy2014 ER - TY - JOUR AU - Ovsyannikova, I. G. AU - Salk, H. M. AU - Larrabee, B. R. AU - Pankratz, V. S. AU - Poland, G. A. PY - 2014 DA - 2014// TI - Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines JO - Immunogenetics VL - 66 UR - https://doi.org/10.1007/s00251-014-0796-z DO - 10.1007/s00251-014-0796-z ID - Ovsyannikova2014 ER - TY - JOUR AU - Liu, D. AU - Tian, Y. AU - Sun, D. AU - Sun, H. AU - Jin, Y. AU - Dong, M. PY - 2016 DA - 2016// TI - The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis JO - Ann Hematol VL - 95 UR - https://doi.org/10.1007/s00277-016-2723-x DO - 10.1007/s00277-016-2723-x ID - Liu2016 ER - TY - JOUR AU - Dahan, R. AU - Sega, E. AU - Engelhardt, J. AU - Selby, M. AU - Korman, A. J. AU - Ravetch, J. V. PY - 2015 DA - 2015// TI - FcgammaRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis JO - Cancer Cell VL - 28 UR - https://doi.org/10.1016/j.ccell.2015.08.004 DO - 10.1016/j.ccell.2015.08.004 ID - Dahan2015 ER - TY - JOUR AU - Wang, C. H. AU - Eng, H. L. AU - Lin, K. H. AU - Liu, H. C. AU - Chang, C. H. AU - Lin, T. M. PY - 2014 DA - 2014// TI - Functional polymorphisms of TLR8 are associated with hepatitis C virus infection JO - Immunology VL - 141 UR - https://doi.org/10.1111/imm.12211 DO - 10.1111/imm.12211 ID - Wang2014 ER - TY - JOUR AU - Wolchok, J. D. AU - Hoos, A. AU - O’Day, S. AU - Weber, J. S. AU - Hamid, O. AU - Lebbe, C. PY - 2009 DA - 2009// TI - Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1624 DO - 10.1158/1078-0432.CCR-09-1624 ID - Wolchok2009 ER - TY - STD TI - Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259–71. ID - ref176 ER - TY - JOUR AU - Ferris, R. L. AU - Galon, J. PY - 2016 DA - 2016// TI - Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification JO - J Natl Cancer Inst VL - 108 UR - https://doi.org/10.1093/jnci/djw033 DO - 10.1093/jnci/djw033 ID - Ferris2016 ER - TY - JOUR AU - Yoshihama, S. AU - Roszik, J. AU - Downs, I. AU - Meissner, T. B. AU - Vijayan, S. AU - Chapuy, B. PY - 2016 DA - 2016// TI - NLRC5/MHC class I transactivator is a target for immune evasion in cancer JO - Proc Natl Acad Sci U S A VL - 113 UR - https://doi.org/10.1073/pnas.1602069113 DO - 10.1073/pnas.1602069113 ID - Yoshihama2016 ER - TY - JOUR AU - Zaretsky, J. M. AU - Garcia-Diaz, A. AU - Shin, D. S. AU - Escuin-Ordinas, H. AU - Hugo, W. AU - Hu-Lieskovan, S. PY - 2016 DA - 2016// TI - Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1604958 DO - 10.1056/NEJMoa1604958 ID - Zaretsky2016 ER - TY - JOUR AU - Spranger, S. AU - Bao, R. AU - Gajewski, T. F. PY - 2015 DA - 2015// TI - Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity JO - Nature VL - 523 UR - https://doi.org/10.1038/nature14404 DO - 10.1038/nature14404 ID - Spranger2015 ER - TY - JOUR AU - Dorand, R. D. AU - Nthale, J. AU - Myers, J. T. AU - Barkauskas, D. S. AU - Avril, S. AU - Chirieleison, S. M. PY - 2016 DA - 2016// TI - Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity JO - Science VL - 353 UR - https://doi.org/10.1126/science.aae0477 DO - 10.1126/science.aae0477 ID - Dorand2016 ER -